Cambridge Nutritional Sciences plc

DB:RVKA Stock Report

Market Cap: €9.3m

Cambridge Nutritional Sciences Past Earnings Performance

Past criteria checks 2/6

Cambridge Nutritional Sciences has been growing earnings at an average annual rate of 23.5%, while the Medical Equipment industry saw earnings declining at 1.1% annually. Revenues have been growing at an average rate of 0.4% per year. Cambridge Nutritional Sciences's return on equity is 1.8%, and it has net margins of 1.9%.

Key information

23.5%

Earnings growth rate

34.2%

EPS growth rate

Medical Equipment Industry Growth4.3%
Revenue growth rate0.4%
Return on equity1.8%
Net Margin1.9%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Cambridge Nutritional Sciences makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:RVKA Revenue, expenses and earnings (GBP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 249060
30 Jun 249060
31 Mar 2410070
31 Dec 239-270
30 Sep 239-370
30 Jun 238-370
31 Mar 238-360
31 Dec 228-360
30 Sep 228-360
30 Jun 228-260
31 Mar 229-160
30 Sep 218140
30 Jun 217140
31 Mar 217050
31 Dec 209-470
30 Sep 209-770
30 Jun 209-770
31 Mar 2010-770
31 Dec 199-470
30 Sep 199060
30 Jun 199060
31 Mar 199060
31 Dec 188-160
30 Sep 188-270
30 Jun 188-170
31 Mar 188-170
31 Dec 1710070
30 Sep 1712080
30 Jun 1713080
31 Mar 1714190
31 Dec 1614180
30 Sep 1613180
30 Jun 1613180
31 Mar 1613180
31 Dec 1513180
30 Sep 1513170
30 Jun 1512170
31 Mar 1512170
31 Dec 1412170
30 Sep 1412170
30 Jun 1412170
31 Mar 1412170
31 Dec 1311170

Quality Earnings: RVKA has a large one-off loss of £61.0K impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: RVKA became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RVKA has become profitable over the past 5 years, growing earnings by 23.5% per year.

Accelerating Growth: RVKA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: RVKA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.1%).


Return on Equity

High ROE: RVKA's Return on Equity (1.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies